secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zentalis Pharmaceuticals, Inc. (ZNTL)
CIK:        0001725160
Form:       8-K
Filed at:   2024-04-09T23:59:59+00:00
Accession:  0001725160-24-000082
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zentalis presents corporate deck at conferences; no new financial or clinical updates disclosed
--------------------------------------------------------------------------------

- Spokespersons to present the April 2024 corporate presentation at investor meetings and conferences.
- Presentation furnished as Exhibit 99.1; no specific material changes or new data provided.
- Filing under Regulation FD; information is furnished not filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725160/000172516024000082/0001725160-24-000082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725160/000172516024000082/zntl-20240409.htm
  HTML page:      https://secwatch.observer/filing/0001725160-24-000082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer